Malaysia

Sabah signs MoU with Kanger International to obtain Sinopharm vaccine

Company will be sole distributor of shots for state after usage approved in country

Updated 5 years ago · Published on 27 May 2021 9:30PM

Sabah signs MoU with Kanger International to obtain Sinopharm vaccine
Kanger International Bhd executive director Steven Kuah says the company would obtain approval from the government through the National Pharmaceutical Regulatory Agency before bringing the supply of Sinopharm into Sabah. – AFP pic, May 27, 2021

KOTA KINABALU – The Sabah government and Kanger International Bhd today signed a memorandum of understanding (MoU) to obtain the supply of Sinopharm vaccine against Covid-19 for people in the state.

Under the MoU, the state government agreed to appoint the company as the sole distributor of Sinopharm vaccine for Sabah after its usage has been approved in this country, while Kanger International will obtain the vaccine to be supplied to the state government.

Sabah Finance Ministry Permanent Secretary Rusdin Riman and Kanger International executive director Steven Kuah signed the MoU at the Sabah State Administrative Centre here today.

Kuah told reporters that the company would obtain approval from the government through the National Pharmaceutical Regulatory Agency (NPRA) before bringing the supply into Sabah.

“The process of registering the Sinopharm vaccine (with NPRA) has started, and we hope to receive the good news of approval for the vaccine soon.

“We believe that cooperation between the public and private sectors will be beneficial and speed up the vaccination exercise in Malaysia,” he said, adding that the total number of doses to be supplied to Sabah would be decided on later.

Kuah said the company viewed this initiative as important to support and complement the government’s efforts towards achieving herd immunity in Malaysia to curb the spread of Covid-19.

Currently, only three types of vaccine against Covid-19 are being used in Malaysia – namely Pfizer-BioNTech, Sinovac, and Oxford-AstraZeneca. – Bernama, May 27, 2021

Related News

Opinion / 1mth

The Malaysia Agreement 1963: Grievances and expectations in Sabah and Sarawak

Malaysia / 1mth

Budget 2027: Sabah, Sarawak to receive RM34.9b in federal allocations next year

Events / 1mth

Sarawak and Sabah play key roles in weathering climate change

Malaysia / 1mth

Address security concerns and let concert proceed – former Sabah CM

Malaysia / 1mth

Dr Noor Hisham denies claims that the Pfizer vaccine caused deaths

Malaysia / 2mth

A message from our publisher and chairman

Spotlight

Malaysia

Bersama, Bersatu fail to win a seat in Melaka, face questions over political future

By Alfian Z.M. Tahir

Malaysia

African man apologises to Malaysians over machete attack on policeman

Malaysia

Two family members to be charged with murder of elderly man in Negeri Sembilan

Malaysia

Kuching student accused of attacking teacher with a deadly weapon sent for mental observation

People

Hans Isaac engaged to former Miss Universe Malaysia Francisca Luhong in Paris proposal

Malaysia

NS Exco: Palace weighs settlement proposals as court hearing postponed

Malaysia

Police hunt answers after 15-year-old girl shot in neck in Ranau

Malaysia

Missing 74-year-old windsurfer found dead off Tanjung Bungah

You may be interested

Malaysia

Suspected fake Selangor Crown Prince aide jailed, caned over RM185,000 cheating cases

Malaysia

PH's Melaka gains point to need for wider political cooperation, says Amirudin

Malaysia

Flash floods hit i-City, Section 7 in Shah Alam after heavy rain

Malaysia

Anwar to push regional security, Myanmar crisis and South China Sea at ASEAN Summit

Malaysia

MPs to press ministers on nutrition law, illegal crypto mining and rural EV infrastructure

Malaysia

More than RM8m drugs seized at Penang airport this year

By Ian McIntyre

Malaysia

Zahid confirms BN will sit out Sarawak polls

Malaysia

Kuching student accused of attacking teacher with a deadly weapon sent for mental observation